Age-related macular degeneration (AMD), which affects about 200 million people worldwide and can result in legal blindness, impairs an area of the eye (retina) used for reading, driving and many other ...

Age-related macular degeneration (AMD), which affects about 200 million people worldwide and can result in legal blindness, ...

During my visit to CES 2025, I sought out a pair of special smart glasses that could give me hope for my son's future.

After Regeneron Chief Scientific Officer George Yancopoulos, M.D., Ph.D., spent more than 25 minutes waxing about the company ...

High and low levels of high-density lipoprotein and a novel single-nucleotide polymorphism were found to be associated with ...

As we get older, it’s common to experience a gradual decline in eyesight, with conditions like cataracts becoming more ...

For the past several years, the halls of the Las Vegas Convention Center have been lousy with AR/VR/XR smart glasses. While ...

The following is a summary of “Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the ...

PulseSight Therapeutics SAS, an ophthalmology biotech company developing disruptive non-viral vectorized therapies with minimally-invasive delivery technology, today announces it has submitted a ...

In this video, Clement K. Chan, MD, FACS, discusses a presentation from the AAO meeting on multimodal imaging to assess geographic atrophy.In a session on diagnostic techniques for identifying and ...

About AXPAXLI AXPAXLI™ (axitinib intravitreal injection, also known as OTX-TKI) is an investigational, bioresorbable, hydrogel incorporating axitinib, a small molecule, multi-target, tyrosine kinase ...

SolidddVision smartglasses, which correct vision for people living with vision loss due to macular degeneration, will debut at CES.